Teresa Binter

5PUBLICATIONS
19CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 02, 2026
B7-H3 (CD276) as a candidate therapeutic target in medullary thyroid cancer.

|Jul 17, 2025
<i>RET</i> Y791F in MEN2: a variant presumed non-pathogenic, yet lacking conclusive evidence of insignificance.

Teresa Binter, Martin Bruno Niederle, Melisa Arikan

|Oct 16, 2024
The Value of Pretherapeutic Basal Calcitonin Cut-Offs for the Therapeutic Strategy and Prediction of Long-Term Outcome of Patients with Medullary Thyroid Cancer-A 30-Year Single-Center Experience.

Martin B Niederle, Teresa Binter, Philipp Riss

|Feb 10, 2024
Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?

Teresa Binter, Sabina Baumgartner-Parzer, Marie Helene Schernthaner-Reiter

|Jul 14, 2020
Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease.

Georg Semmler, Teresa Binter, Karin Kozbial

Pageof 1

Frequent Collaborators

2 joint publications

Martin Bruno Niederle

1 joint publications

Georg Semmler

1 joint publications

Philipp Schwabl

1 joint publications

David Chromy